Eli Lilly defeats challenge to Alimta cancer drug patent Ruby Khatun Khatun8 Oct 2017 9:30 AM ISTA federal patent review board on Thursday rejected a challenge to a patent covering Eli Lilly and Co’s Alimta drug to treat some lung cancers and...
Roche bladder cancer drug struggles as medics focus on survival Ruby Khatun Khatun8 Oct 2017 9:15 AM ISTLONDON: Roche’s immunotherapy drug Tecentriq has lost market share to Merck & Co’s rival Keytruda since a clinical trial showed the Swiss...
Teva faces generic competition in Europe for Copaxone after US hit Ruby Khatun Khatun8 Oct 2017 9:00 AM ISTLONDON: Teva’s blockbuster multiple sclerosis treatment Copaxone will face additional generic competition in Europe, just two days after Mylan NV won...
FIR against Hetero and Aurobindo pharma Ruby Khatun Khatun7 Oct 2017 1:36 PM ISTHYDERABAD: 13 pharmaceutical companies have got notices from Telangana State Pollution Control Board (TSPCB) for contaminating and polluting Kazipally...
Safe, effective DNA-based Zika vaccine developed Ruby Khatun Khatun7 Oct 2017 10:58 AM ISTWashington: A new generation DNA-based Zika vaccine has been found safe and effective at eliciting an immune response against the virus in early human...
Novartis divests anti-infectives brands to Samara Capital Ruby Khatun Khatun7 Oct 2017 10:56 AM ISTNew Delhi: Global pharma major Novartis AG said it has divested some of its anti-infectives brands mainly catering to the women's healthcare to...
Gilead Sciences completes acquisition of Kite Pharma in 11.9 billion dollar Ruby Khatun Khatun7 Oct 2017 10:00 AM ISTFOSTER CITY, Calif.: Gilead Sciences, Inc. announced the completion of the previously announced transaction for Dodgers Merger Sub, Inc., a...
US court reverses ban on sale of Regeneron, Sanofi cholesterol drug Ruby Khatun Khatun7 Oct 2017 9:45 AM ISTA U.S. appeals court on Thursday threw out a ban on the sale of Regeneron Pharmaceuticals Inc and Sanofi SA’s cholesterol-lowering drug Praluent and...
Mylan surges, Teva slumps after FDA approves Copaxone copy Ruby Khatun Khatun7 Oct 2017 9:30 AM ISTMylan NV’s long-awaited U.S. approval for its generic version of rival Teva’s blockbuster multiple sclerosis treatment Copaxone drove Mylan’s shares...
Sterigenics partners with Noxilizer to provide NO2 sterilization for pharma, biotech and medical device products Ruby Khatun Khatun7 Oct 2017 9:15 AM ISTBALTIMORE and BROADVIEW HEIGHTS, Ohio: Noxilizer, Inc. and Sterigenics International LLC announce the signing of a global agreement that will make...
Health ministry releases Mobile APP for ADR reporting, Pharmacovigilance guidelines, Ruby Khatun Khatun6 Oct 2017 4:32 PM ISTNew Delhi: The Secretary, Ministry of Health and Family Welfare, Government of India has launched a mobile app for ADR reporting and pharmacovigilance...
Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent Ruby Khatun Khatun6 Oct 2017 11:12 AM ISTAHMEDABAD: Intas Pharmaceuticals Limited, announced that the company is cutting down the cost of the cancer drug Bevacizumab by 60 percent in order to...
